Prevalence and factors associated with lipid-lowering medications use for primary and secondary prevention of cardiovascular diseases among Malaysians: the REDISCOVER study

• Autori principali: Noorhida Baharudin (Autore), Mohamed-Syarif M (Autore), Aqil Mohammad Daher (Autore), Anis Safura Ramli (Autore), Nor-Ashikin Mohamed Noor Khan (Autore), Suraya Abdul-Razak (Autore)
• Natura: Libro
• Pubblicazione: BMC, 2022-02-01T00:00:00Z.
• Soggetti: article
• Accesso online: Connect to this object online.

Abstract Background Lipid-lowering medications (LLM) are commonly used for secondary prevention, as well as for primary prevention among patients with high global cardiovascular risk and with diabetes. This study aimed to determine the prevalence of LLM use among high-risk individuals [participants...